4.5 Article

Clinical and molecular features of 66 patients with musculocontractural Ehlers-Danlos syndrome caused by pathogenic variants in CHST14 (mcEDS-CHST14)

期刊

JOURNAL OF MEDICAL GENETICS
卷 59, 期 9, 页码 865-877

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2020-107623

关键词

musculoskeletal diseases; human genetics

资金

  1. Ministry of Health, Labour and Welfare, Japan [073, 20FC1046]
  2. Japan Agency for Medical Research and Development (AMED) [105, 16kk0205001h0501, 16kk0205012h1001, JP19ek0109280, JP19dm0107090, JP19ek0109301, JP19ek0109348, JP18kk020501, 19ek0109301h0002]
  3. Japan Society for the Promotion of Science, Japan [25460405, 19H03616, JP19H03621]
  4. Medical Research Encouragement Prize of the Japan Medical Association
  5. Japan Foundation for Pediatric Research
  6. Problem-Solving Oriented Training Programme for Advanced Medical Personnel: NGSD (Next Generation Super Doctor) Project
  7. Intramural Research Programme of the National Human Genome Research Institute
  8. BML Inc.
  9. Life Technologies Japan Ltd.
  10. Grants-in-Aid for Scientific Research [19H03616, 25460405] Funding Source: KAKEN

向作者/读者索取更多资源

This study systematically investigated Musculocontractural Ehlers-Danlos syndrome caused by biallelic loss-of-function variants in CHST14, revealing it as a multisystem disorder with unique clinical phenotypes consisting of multiple malformations and progressive fragility-related manifestations requiring lifelong, multidisciplinary healthcare approaches.
Background Musculocontractural Ehlers-Danlos syndrome is caused by biallelic loss-of-function variants in CHST14 (mcEDS-CHST14) or DSE (mcEDS-DSE). Although 48 patients in 33 families with mcEDS-CHST14 have been reported, the spectrum of pathogenic variants, accurate prevalence of various manifestations and detailed natural history have not been systematically investigated. Methods We collected detailed and comprehensive clinical and molecular information regarding previously reported and newly identified patients with mcEDS-CHST14 through international collaborations. Results Sixty-six patients in 48 families (33 males/females; 0-59 years), including 18 newly reported patients, were evaluated. Japanese was the predominant ethnicity (27 families), associated with three recurrent variants. No apparent genotype-phenotype correlation was noted. Specific craniofacial (large fontanelle with delayed closure, downslanting palpebral fissures and hypertelorism), skeletal (characteristic finger morphologies, joint hypermobility, multiple congenital contractures, progressive talipes deformities and recurrent joint dislocation), cutaneous (hyperextensibility, fine/acrogeria-like/wrinkling palmar creases and bruisability) and ocular (refractive errors) features were observed in most patients (>90%). Large subcutaneous haematomas, constipation, cryptorchidism, hypotonia and motor developmental delay were also common (>80%). Median ages at the initial episode of dislocation or large subcutaneous haematoma were both 6 years. Nine patients died; their median age was 12 years. Several features, including joint and skin characteristics (hypermobility/extensibility and fragility), were significantly more frequent in patients with mcEDS-CHST14 than in eight reported patients with mcEDS-DSE. Conclusion This first international collaborative study of mcEDS-CHST14 demonstrated that the subtype represents a multisystem disorder with unique set of clinical phenotypes consisting of multiple malformations and progressive fragility-related manifestations; these require lifelong, multidisciplinary healthcare approaches.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据